About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [221 citations: 1–100 of 220 articles]

Articles published in Chemotherapy Research and Practice have been cited 221 times. The following is a list of the 220 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Na Li, Gang Chen, Jue Liu, Yang Xia, Hanbang Chen, Hui Tang, Feimin Zhang, and Ning Gu, “Effect of Surface Topography and Bioactive Properties on Early Adhesion and Growth Behavior of Mouse Preosteoblast MC3T3-E1 Cells,” Acs Applied Materials & Interfaces, vol. 6, no. 19, pp. 17134–17143, 2014. View at Publisher · View at Google Scholar
  • Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, and Aeree Kim, “Role of erbB3 receptors in cancer therapeutic resistance,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 3, pp. 190–198, 2014. View at Publisher · View at Google Scholar
  • Maria Hakanson, Edna Cukierman, and Mirren Charnley, “Miniaturized pre-clinical cancer models as research and diagnostic tools,” Advanced Drug Delivery Reviews, vol. 69, pp. 52–66, 2014. View at Publisher · View at Google Scholar
  • Xinghao Ai, Yingjia Sun, Haidong Wang, and Shun Lu, “A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity,” Amino Acids, vol. 46, no. 7, pp. 1635–1648, 2014. View at Publisher · View at Google Scholar
  • Chongjiao Li, Xiaoli Lan, Hui Yuan, Hongyan Feng, Xiaotian Xia, and Yongxue Zhang, “F-18-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis,” Annals of Nuclear Medicine, vol. 28, no. 5, pp. 436–446, 2014. View at Publisher · View at Google Scholar
  • Edgar D. Staren, Donald Braun, Bradford Tan, Digant Gupta, Seungchan Kim, Kim Kramer, and Maurie Markman, “Initial Experience with Genomic Profiling of Heavily Pretreated Breast Cancers,” Annals of Surgical Oncology, vol. 21, no. 10, pp. 3216–3222, 2014. View at Publisher · View at Google Scholar
  • Margherita Ratti, “Emerging combination therapies to overcome resistance in EGFR-driven tumors,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 127–139, 2014. View at Publisher · View at Google Scholar
  • Parisa Ghanbari, Mahsa Mohseni, Maryam Tabasinezhad, Bahman Yousefi, Amir Ata Saei, Simin Sharifi, Mohammad Reza Rashidi, and Nasser Samadi, “Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine,” Applied Biochemistry and Biotechnology, 2014. View at Publisher · View at Google Scholar
  • Sabit Sinan Ozalp, Elcin Telli, Tufan Oge, Gokhan Tulunay, Nurettin Boran, Taner Turan, Mufit Yenen, Zehra Kurdoglu, Ali Ozler, Kunter Yuce, Volkan Ulker, Macit Arvas, Fuat Demirkiran, Tugan Bese, Nedim Tokgozoglu, Anil Onan, Muzaffer Sanci, Mehmet Gokcu, Gokhan Tosun, Yilmaz Dikmen, Aydin Ozsaran, Mustafa Cosan Terek, Levent Akman, Hakan Yetimalar, Derya Sakarya Kilic, Tayfun Gungor, Emre Ozgu, Yunus Yildiz, Arif Kokcu, Mehmet Kefeli, Serkan Kuruoglu, Hasan Yuksel, Tevfik Guvenal, Pinar Solmaz Hasdemir, Bulent Ozcelik, Serdar Serin, Mehmet Dolanbay, Dagistan Tolga Arioz, Nadire Tuncer, Hasan Bozkaya, Suleyman Guven, Deniz Kulaksiz, Fusun Varol, Ali Yanik, Gonca Ogurlu, Tayyup Simsek, Tayfun Toptas, Selen Dogan, Hakan Camuzoglu, Murat Api, Kadir Guzin, Eray Caliskan, Emek Doger, Bulent Cakmak, and Tolgay Tuyan Ilhan, “Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 8, pp. 3625–3628, 2014. View at Publisher · View at Google Scholar
  • Helen Creedon, Adam Byron, Joanna Main, Larry Hayward, Teresa Klinowska, and Valerie G. Brunton, “Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer,” Biochemical Society Transactions, vol. 42, pp. 822–830, 2014. View at Publisher · View at Google Scholar
  • Veronica Morente, Raquel Perez-Sen, Felipe Ortega, Jaime Huerta-Cepas, Esmerilda G. Delicado, and Ma Teresa Miras-Portugal, “Neuroprotection elicited by P2Y(13) receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery,” Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 9, pp. 1886–1898, 2014. View at Publisher · View at Google Scholar
  • Yijie Lu, Ghislaine Ngo Ndjock Mbong, Peng Liu, Conrad Chan, Zhongli Cai, Dirk Weinrich, Amanda J. Boyle, Raymond M. Reilly, and Mitchell A. Winnik, “Synthesis of Polyglutamide-Based Metal-Chelating Polymers and Their Site-Specific Conjugation to Trastuzumab for Auger Electron Radioimmunotherapy,” Biomacromolecules, vol. 15, no. 6, pp. 2027–2037, 2014. View at Publisher · View at Google Scholar
  • Sandhya V. G. Nair, Menik Hettihewa, and H. P. Vasantha Rupasinghe, “Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Peeyush N. Goel, and Rajiv P. Gude, “Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 93–99, 2014. View at Publisher · View at Google Scholar
  • Liyan Jiang, Wei Zhu, Katie Streicher, Chris Morehouse, Philip Brohawn, Xiaoxiao Ge, Zhengwei Dong, Xiaolu Yin, Guanshan Zhu, Yi Gu, Koustubh Ranade, Brandon W. Higgs, Yihong Yao, and Jiaqi Huang, “Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Lu Chen, Hannah M. Linden, Benjamin O. Anderson, and Christopher I. Li, “Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage,” Breast Cancer Research and Treatment, vol. 147, no. 3, pp. 609–616, 2014. View at Publisher · View at Google Scholar
  • S. Li, L. Li, Y. Zhu, C. Huang, Y. Qin, H. Liu, L. Ren-Heidenreich, B. Shi, H. Ren, X. Chu, J. Kang, W. Wang, J. Xu, K. Tang, H. Yang, Y. Zheng, J. He, G. Yu, and N. Liang, “Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts,” British Journal of Cancer, vol. 110, no. 11, pp. 2812–2820, 2014. View at Publisher · View at Google Scholar
  • Matthew T. Balmer, Ryan D. Katz, Si Liao, James S. Goodwine, and Susannah Gal, “Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells,” Cancer Biology & Therapy, vol. 15, no. 8, pp. 1000–1012, 2014. View at Publisher · View at Google Scholar
  • Malgorzata K. Tuxen, and Dorte Lisbet Nielsen, “A systematic review of dual targeting in HER2-positive breast cancer,” Cancer Treatment Reviews, vol. 40, no. 2, pp. 259–270, 2014. View at Publisher · View at Google Scholar
  • Lijuan Yang, Yuexun Wang, Hua Guo, and Meiling Guo, “Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma,” Cell Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  • Dalila Naci, and Fawzi Aoudjit, “Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways,” Cellular Signalling, 2014. View at Publisher · View at Google Scholar
  • Hilde van Hattum, and Herbert Waldmann, “Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time,” Chemistry & Biology, vol. 21, no. 9, pp. 1185–1195, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Marta Castiglia, Sergio Rizzo, Francesca Lo Vullo, Eugenio Fiorentino, Jan Van Meerbeeck, and Antonio Russo, “Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects,” Critical Reviews in Oncology Hematology, vol. 89, no. 2, pp. 300–313, 2014. View at Publisher · View at Google Scholar
  • Yuan Zhang, Yukun Liu, Yan Sun, Qingmei Liu, Xiaoyan Wang, Zhi Li, and Jie Hao, “In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics Against Multidrug-Resistant Clinical Isolates,” Current Microbiology, vol. 68, no. 6, pp. 685–692, 2014. View at Publisher · View at Google Scholar
  • Megan Lyle, and Georgina V. Long, “The role of systemic therapies in the management of melanoma brain metastases,” Current Opinion in Oncology, vol. 26, no. 2, pp. 222–229, 2014. View at Publisher · View at Google Scholar
  • K. Chanprapaph, V. Vachiramon, and P. Rattanakaemakorn, “Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management,” Dermatology Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Hale Colakoglu Er, Ayse Erden, N. Ozlem Kucuk, and Ethem Gecim, “Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma,” Diagnostic and Interventional Radiology, vol. 20, no. 2, pp. 105–109, 2014. View at Publisher · View at Google Scholar
  • Cheng-Cheung Chen, Dar-Shih Hsieh, Kao-Jean Huang, Yi-Lin Chan, Po-Da Hong, Ming-Kung Yeh-, and Chang-Jer Wu, “Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells,” Drug Design Development and Therapy, vol. 8, pp. 459–473, 2014. View at Publisher · View at Google Scholar
  • Fatima el Bahhaj, Frank J. Dekker, Nadine Martinet, and Philippe Bertrand, “Delivery of epidrugs,” Drug Discovery Today, 2014. View at Publisher · View at Google Scholar
  • Mi Ryoung Choi, Nam Jin Yoo, and Sug Hyung Lee, “Oncogenic ERBB3 mutations altering p.Val104 is rare in acute leukemias and non-Hodgkin lymphomas,” European Journal of Haematology, vol. 92, no. 2, pp. 177–178, 2014. View at Publisher · View at Google Scholar
  • Aleksandar Savić, Lana Filipović, Sandra Aranđelović, Biljana Dojčinović, Siniša Radulović, Tibor J. Sabo, and Sanja Grgurić-Šipka, “Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes,” European Journal of Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Poonam Sharma, Pawas Goswami, Vikas Sangwan, and Rameshwar Singh, “Antibiotic resistance among commercially available probiotics,” Food Research International, vol. 57, pp. 176–195, 2014. View at Publisher · View at Google Scholar
  • Stephanie Shishido, Halvard Bönig, and Yong-Mi Kim, “Role of Integrin Alpha4 in Drug Resistance of Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Zhongbo Hu, and William B. Slayton, “Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • V. K. Kolli, K. Natarajan, B. Isaac, D. Selvakumar, and P. Abraham, “Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis,” Human & Experimental Toxicology, vol. 33, no. 10, pp. 1051–1065, 2014. View at Publisher · View at Google Scholar
  • V. M. Patil, S. Chakraborty, P. K. Shenoy, A. Manuprasad, Sajith T. P. Babu, T. Shivkumar, S. Babu, A. Bhatterjee, and S. Balasubramanian, “Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center,” Indian Journal of Cancer, vol. 51, no. 1, pp. 69–72, 2014. View at Publisher · View at Google Scholar
  • Valeria Ferretti, Marco Fogagnolo, Andrea Marchi, Lorenza Marvelli, Fabio Sforza, and Paola Bergamini, “Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents,” Inorganic Chemistry, pp. 140506130435009, 2014. View at Publisher · View at Google Scholar
  • Junjun Yang, Yang Xiang, Xirun Wan, Fengzhi Feng, and Tong Ren, “Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia,” International Journal of Gynecological Cancer, vol. 24, no. 3, pp. 594–599, 2014. View at Publisher · View at Google Scholar
  • Qing Xia, Yuchen Cai, Roujun Peng, Guosheng Wu, Yanxia Shi, and Wenqi Jiang, “The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition,” International Journal of Oncology, vol. 44, no. 3, pp. 735–744, 2014. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma,” International Journal of Pharmaceutics, 2014. View at Publisher · View at Google Scholar
  • Gershon Volpin, Miri Cohen, Michael Assaf, Tamar Meir, Rina Katz, and Shimon Pollack, “Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients,” International Orthopaedics, 2014. View at Publisher · View at Google Scholar
  • Anthony Kodzo-Grey Venyo, “Primary Clear Cell Carcinoma of the Urinary Bladder,” International Scholarly Research Notices, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Kimiko Hirata, Takeshi Kodaira, Natsuo Tomita, Yukihiko Ohshima, Junji Ito, Hiroyuki Tachibana, Toru Nakanishi, and Nobukazu Fuwa, “Clinical Efficacy of Alternating Chemoradiotherapy by Conformal Radiotherapy Combined with Intracavitary Brachytherapy for High-risk Cervical Cancer,” Japanese Journal of Clinical Oncology, vol. 44, no. 6, pp. 556–563, 2014. View at Publisher · View at Google Scholar
  • William F. Anderson, Philip S. Rosenberg, and Hormuzd A. Katki, “Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast Cancer,” Jnci-Journal of The National Cancer Institute, vol. 106, no. 5, 2014. View at Publisher · View at Google Scholar
  • Keith R. Laderoute, Joy M. Calaoagan, Wan-ru Chao, Dominc Dinh, Nicholas Denko, Sarah Duellman, Jessica Kalra, Xiaohe Liu, Ioanna Papandreou, Lidia Sambucetti, and Laszlo G. Boros, “5 '-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors,” Journal of Biological Chemistry, vol. 289, no. 33, pp. 22850–22864, 2014. View at Publisher · View at Google Scholar
  • Su-Jin Shin, Gyungyub Gong, Hee Jin Lee, Jun Kang, Young Kyung Bae, Ahwon Lee, Eun Yoon Cho, Ji Shin Lee, Kwang-Sun Suh, Dong Wha Lee, and Woo Hee Jung, “Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer,” Journal of Breast Cancer, vol. 17, no. 2, pp. 113–120, 2014. View at Publisher · View at Google Scholar
  • Li-Fen Hu, Li-Ping Gao, Ying Ye, Xi Chen, Xiang-Tian Zhou, Hai-Fei Yang, Yan-Yan Liiu, Qing Mei, and Jia-Bin Li, “Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations,” Journal of Chemotherapy, vol. 26, no. 5, pp. 282–286, 2014. View at Publisher · View at Google Scholar
  • Shutao Guo, Lei Miao, Yuhua Wang, and Leaf Huang, “Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy,” Journal of Controlled Release, vol. 174, pp. 137–142, 2014. View at Publisher · View at Google Scholar
  • Farshad Homayouni Moghadam, Maryam Dehghan, Ehsan Zarepur, Reyhaneh Dehlavi, Fatemeh Ghaseminia, Shima Ehsani, Golnaz Mohammadzadeh, and Kazem Barzegar, “Oleo gum resin of Ferula assa-foetida L. ameliorates peripheral neuropathy in mice,” Journal of Ethnopharmacology, 2014. View at Publisher · View at Google Scholar
  • Myo Min, Daniel Roos, Elly Keating, Michael Penniment, Scott Carruthers, Lydia Zanchetta, Karen Wong, John Shakeshaft, and Siddhartha Baxi, “External evaluation of the Radiation Therapy Oncology Group brachial plexus contouring protocol: Several issues identified,” Journal of Medical Imaging and Radiation Oncology, vol. 58, no. 3, pp. 360–368, 2014. View at Publisher · View at Google Scholar
  • Jeremy Rees, “Updates in the management of high-grade glioma,” Journal of Neurology, vol. 261, no. 4, pp. 651–654, 2014. View at Publisher · View at Google Scholar
  • Emanuela Binello, Elisabetta Mormone, Luni Emdad, Harini Kothari, and Isabelle M. Germano, “Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Gordon A. G. McKenzie, Emma E. Hinsley, Keith Hunter, and Daniel W. Lambert, “The endothelin axis in head and neck cancer: a promising therapeutic opportunity?,” Journal of Oral Pathology & Medicine, vol. 43, no. 6, pp. 395–404, 2014. View at Publisher · View at Google Scholar
  • Keita Mizuno, Toru Kono, Yasuyuki Suzuki, Chika Miyagi, Yuji Omiya, Kanako Miyano, Yoshio Kase, and Yasuhito Uezono, “Goshajinkigan, a Traditional Japanese Medicine, Prevents Oxaliplatin-Induced Acute Peripheral Neuropathy by Suppressing Functional Alteration of TRP Channels in Rat,” Journal of Pharmacological Sciences, vol. 125, no. 1, pp. 91–98, 2014. View at Publisher · View at Google Scholar
  • Claire Marie Reyes-Habito, and Ellen K. Roh, “Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer Part II. Targeted therapies,” Journal of The American Academy of Dermatology, vol. 71, no. 2, 2014. View at Publisher · View at Google Scholar
  • Guido Cavaletti, “Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know,” Journal of The Peripheral Nervous System, vol. 19, no. 2, pp. 66–76, 2014. View at Publisher · View at Google Scholar
  • Noyko S. Stanilov, Iliya A. Karakolev, Tashko S. Deliysky, Jovcho P. Jovchev, and Spaska A. Stanilova, “Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  • Jian Ma, Hui Lyu, and Jingcao Huang, “Targeting of erbB3 receptor to overcome resistance in cancer treatment,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Shikha Gaur, Linling Chen, Vincent Ann, Wei-Chen Lin, Yafan Wang, Vincent H. S. Chang, Nan Yong Hsu, Her-Shuyong Shia, and Yun Yen, “Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Ning Jiang, Dongsheng Wang, Zhongliang Hu, Hyung Ju C. Shin, Guoqing Qian, Mohammad Aminur Rahman, Hongzheng Zhang, A. R. M. Ruhul Amin, Sreenivas Nannapaneni, Xiaojing Wang, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Jun Ma, Zhuo G. Chen, and Nabil F. Saba, “Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma,” Molecular Cancer Therapeutics, vol. 13, no. 7, pp. 1826–1836, 2014. View at Publisher · View at Google Scholar
  • Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, Jean-Marie Stephan, and Kimberly K. Leslie, “Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers,” Molecular Diagnosis & Therapy, vol. 18, no. 2, pp. 137–151, 2014. View at Publisher · View at Google Scholar
  • Hao Jiang, Peng-Jun Zhao, Dan Su, Jianguo Feng, and Sheng-Lin Ma, “Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo,” Molecular Medicine Reports, vol. 9, no. 6, pp. 2265–2272, 2014. View at Publisher · View at Google Scholar
  • R Guabiraba, A G Besnard, G B Menezes, T Secher, M S Jabir, S S Amaral, H Braun, R Cp Lima-Junior, R A Ribeiro, F Q Cunha, M M Teixeira, R Beyaert, G J Graham, and F Y Liew, “IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice,” Mucosal Immunology, 2014. View at Publisher · View at Google Scholar
  • Gagan Deep, Rahul Kumar, Anil K. Jain, Chapla Agarwal, and Rajesh Agarwal, “Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • Supratim Ghosh, Kamil B. Ucer, Ralph D'Agostino, Ken Grant, Joseph Sirintrapun, Michael J. Thomas, Roy Hantgan, Manish Bharadwaj, and William H. Gmeiner, “Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity,” Nanomedicine-Nanotechnology Biology and Medicine, vol. 10, no. 2, pp. 451–461, 2014. View at Publisher · View at Google Scholar
  • Marianna Lucafo, Chiara Pelillo, Marco Carini, Tatiana Da Ros, Maurizio Prato, and Gianni Sava, “A Cationic 60 Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival,” Nano-Micro Letters, vol. 6, no. 2, pp. 163–168, 2014. View at Publisher · View at Google Scholar
  • Marjo-Riitta Puumalainen, Davor Lessel, Peter Ruethemann, Nina Kaczmarek, Karin Bachmann, Kristijan Ramadan, and Hanspeter Naegeli, “Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity,” Nature Communications, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Zhao Chen, Christine M. Fillmore, Peter S. Hammerman, Carla F. Kim, and Kwok-Kin Wong, “Non-small-cell lung cancers: a heterogeneous set of diseases,” Nature Reviews Cancer, vol. 14, no. 8, pp. 535–546, 2014. View at Publisher · View at Google Scholar
  • Helmout Modjtahedi, Byoung Chul Cho, Martin C. Michel, and Flavio Solca, “A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer,” Naunyn-Schmiedebergs Archives of Pharmacology, vol. 387, no. 6, pp. 505–521, 2014. View at Publisher · View at Google Scholar
  • Tania E. Schwingel, Caroline P. Klein, Natalia F. Nicoletti, Cristiana L. Dora, Gabriela Hadrich, Cláudia G. Bica, Tiago G. Lopes, Vinicius Duval da Silva, and Fernanda B. Morrone, “Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • M. Straka, M. Skrovina, R. Soumarova, R. Kotasek, L. Burda, and C. Vojtek, “Up front hepatectomy for metastatic rectal carcinoma - reversed, liver first approach. Early experience with 15 patients,” Neoplasma, vol. 61, no. 4, pp. 447–452, 2014. View at Publisher · View at Google Scholar
  • David E. Piccioni, Julia Selfridge, Reema R. Mody, Reshmi Chowdhury, Sichen Li, Shadi Lalezari, James Wawrzynski, Jennifer Quan, Mira Zurayk, Arthur P. Chou, Desiree E. Sanchez, Linda M. Liau, Benjamin M. Ellingson, Whitney B. Pope, Phioanh L. Nghiemphu, Richard M. Green, He-jing Wang, William H. Yong, Robert Elashoff, Timothy F. Cloughesy, and Albert Lai, “Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy,” Neuro-Oncology, vol. 16, no. 6, pp. 815–822, 2014. View at Publisher · View at Google Scholar
  • Senthilvelan Manohar, Samson Jamesdaniel, and Richard Salvi, “Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes,” Neurotoxicity Research, vol. 25, no. 4, pp. 369–380, 2014. View at Publisher · View at Google Scholar
  • Albert Ale, Jordi Bruna, Xavier Navarro, and Esther Udina, “Neurotoxicity induced by antineoplastic proteasome inhibitors,” Neurotoxicology, vol. 43, pp. 28–35, 2014. View at Publisher · View at Google Scholar
  • Haydar Ali Erken, Emine Rabia Koç, Haşmet Yazıcı, Arzu Yay, Gözde Özge Önder, and Saim Furkan Sarıcı, “Selenium Partially Prevents Cisplatin-Induced Neurotoxicity: A Preliminary Study,” NeuroToxicology, 2014. View at Publisher · View at Google Scholar
  • Kevin Chu Foy, Megan J. Miller, Jay Overholser, Siobhan M. Donnelly, Rita Nahta, and Pravin T.P. Kaumaya, “IGF-1R Peptide Vaccines/ Mimics Inhibit the Growth of BxPC3 and JIMT-1 Cancer Cells in vitro and in vivo and Combined Therapy with HER-1 and HER-2 Peptides Induces Effective Anti-tumor Effects.,” OncoImmunology, pp. 00–00, 2014. View at Publisher · View at Google Scholar
  • Yongshan Yao, Shenghan Chen, Xin Zhou, Li Xie, and Aijun Chen, “5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells,” Oncology Letters, vol. 7, no. 2, pp. 541–547, 2014. View at Publisher · View at Google Scholar
  • Fumihiro Yamaguchi, Kunihiko Fukuchi, Yohei Yamazaki, Hiromi Takayasu, Sakiko Tazawa, Hidetsugu Tateno, Eisuke Kato, Aya Wakabayashi, Mami Fujimori, Takuya Iwasaki, Makoto Hayashi, Yutaka Tsuchiya, Jun Yamashita, Norikazu Takeda, and Fumio Kokubu, “Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-na ve patient: A report of three cases,” Oncology Letters, vol. 7, no. 2, pp. 357–360, 2014. View at Publisher · View at Google Scholar
  • Jordi Martinez-Serra, Antonio Gutierrez, Saul Munoz-Capo, Maria Navarro-Palou, Teresa Ros, Juan Carlos Amat, Bernardo Lopez, Toni F. Marcus, Laura Fueyo, Angela G. Suquia, Jordi Gines, Francisco Rubio, Rafael Ramos, and Joan Besalduch, “xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies,” Oncotargets and Therapy, vol. 7, pp. 985–994, 2014. View at Publisher · View at Google Scholar
  • Christiane R. Maroun, and Tracey Rowlands, “The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 316–338, 2014. View at Publisher · View at Google Scholar
  • Carlo Barone, Carmine Pinto, Nicola Normanno, Lorenzo Capussotti, Francesco Cognetti, Alfredo Falcone, and Lorenzo Mantovani, “KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Farah Khalil, and Scott Antonia, “PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells ,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Shu-Han Wu, Kuang-Li Lee, Ruei-Hung Weng, Zhao-Xian Zheng, Arthur Chiou, and Pei-Kuen Wei, “Dynamic Monitoring of Mechano-Sensing of Cells by Gold Nanoslit Surface Plasmon Resonance Sensor,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Are Hugo Pripp, and Milo Stanisic, “The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients Assessed with Factor Analysis,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Giannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, Helen P. Kourea, George Kouvatseas, Eleni Timotheadou, Pantelis Zebekakis, Ioannis Efstratiou, Helen Gogas, Chrisanthi Vamvouka, Sofia Chrisafi, Anastasios Stofas, George Pentheroudakis, Angelos Koutras, Eleni Galani, Dimitrios Bafaloukos, and George Fountzilas, “Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • David Bates, Suraj Abraham, Michael Campbell, Ingeborg Zehbe, and Laura Curiel, “Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Anna Dvorkin-Gheva, and John A. Hassell, “Identification of a Novel Luminal Molecular Subtype of Breast Cancer,” Plos One, vol. 9, no. 7, 2014. View at Publisher · View at Google Scholar
  • Mark R. Kelley, Yanlin Jiang, Chunlu Guo, April Reed, Hongdi Meng, and Michael R. Vasko, “Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Iman Habibi, Effat S. Emamian, and Ali Abdi, “Advanced Fault Diagnosis Methods in Molecular Networks,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • Naama Kanarek, Sergei I. Grivennikov, Michael Leshets, Audrey Lasry, Irit Alkalay, Elad Horwitz, Yoav D. Shaul, Matthew Stachler, Elena Voronov, Ron N. Apte, Michele Pagano, Eli Pikarsky, Sankar Ghosh, and Yinon Ben-Neriah, “Critical role for IL-1 beta in DNA damage-induced mucositis,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 6, pp. E702–E711, 2014. View at Publisher · View at Google Scholar
  • Peng Guo, Jing Huang, Liya Wang, Di Jia, Jiang Yang, Deborah A. Dillon, David Zurakowski, Hui Mao, Marsha A. Moses, and Debra T. Auguste, “ICAM-1 as a molecular target for triple negative breast cancer,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 41, pp. 14710–14715, 2014. View at Publisher · View at Google Scholar
  • Koji Taniguchi, and Michael Karin, “IL-6 and related cytokines as the critical lynchpins between inflammation and cancer,” Seminars in Immunology, 2014. View at Publisher · View at Google Scholar
  • Deirdre R. Pachman, James C. Watson, Maryam B. Lustberg, Nina D. Wagner-Johnston, Alexandre Chan, Larry Broadfield, Yin Ting Cheung, Christopher Steer, Dawn J. Storey, Kavita D. Chandwani, Judith Paice, Pascal Jean-Pierre, Jeong Oh, Jayesh Kamath, Marie Fallon, Herwig Strik, Susanne Koeppen, and Charles L. Loprinzi, “Management options for established chemotherapy-induced peripheral neuropathy,” Supportive Care in Cancer, 2014. View at Publisher · View at Google Scholar
  • Stephen Sonis, Linda Elting, Dorothy Keefe, Hoang Nguyen, Steven Grunberg, Pamela Randolph-Jackson, and Michael Brennan, “Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung,” Supportive Care in Cancer, 2014. View at Publisher · View at Google Scholar
  • Guang-Ning Yan, Lang Yang, Yang-Fan Lv, Yu Shi, Li-Li Shen, Xiao-Hong Yao, Qiao-Nan Guo, Peng Zhang, You-Hong Cui, Xia Zhang, Xiu-Wu Bian, and De-Yu Guo, “Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway,” The Journal of Pathology, 2014. View at Publisher · View at Google Scholar
  • Sai-Mei Hou, Goran Pershagen, N. Peter Wiklund, Fredrik Nyberg, and Petra J. de Verdier, “The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers,” Tumor Biology, vol. 35, no. 5, pp. 4425–4434, 2014. View at Publisher · View at Google Scholar
  • Theresa M. Allen, and Pieter R. Cullis, “Liposomal drug delivery systems: From concept to clinical applications,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar
  • Hardeep S. Oberoi, Natalia V. Nukolova, Alexander V. Kabanov, and Tatiana K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, 2013. View at Publisher · View at Google Scholar
  • Andrew T. Chan, Reiko Nishihara, Charles S. Fuchs, Edward Giovannucci, Teppei Morikawa, Aya Kuchiba, Shuji Ogino, Paul Lochhead, Kaori Shima, Ichiro Kawachi, Zhi Rong Qian, Mai Yamauchi, Xiaoyun Liao, Yu Imamura, and Katsuhiko Nosho, “A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification,” American Journal Of Epidemiology, vol. 178, no. 1, pp. 84–100, 2013. View at Publisher · View at Google Scholar
  • Harriet Wikman, Markus Glatzel, Burkhard Brandt, Ina Hohensee, Volkmar Mueller, Klaus Pantel, Sabine Riethdorf, Jakob Matschke, Manfred Westphal, Katrin Lamszus, Soenke Meyer-Staeckling, and Isabell Witzel, “Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases,” American Journal Of Pathology, vol. 183, no. 1, pp. 83–95, 2013. View at Publisher · View at Google Scholar